Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-08-23
2009-11-17
Kwon, Brian-Yong S (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07618986
ABSTRACT:
2-Nitroimidazolyl-alkylaminoquinolines, and compositions containing the same, useful in the treatment of tuberculosis are disclosed. Methods of treating tuberculosis using the 2-nitroimidazolyl-alkylaminoquinolines, and compositions containing the same, also are disclosed.
REFERENCES:
patent: 5294715 (1994-03-01), Papadopoulou-Rosenzweig et al.
patent: 5602142 (1997-02-01), Papadopoulou-Rosenzweig et al.
patent: 5958947 (1999-09-01), Papadopoulou-Rosenzweig et al.
Barry et al., Current Pharmaceutical Design, 10:3239-3262, 2004.
Bloomer William D.
Papadopoulou Maria V.
Baek Bong-Sook
Evanston Northwestern Healthcare
Kwon Brian-Yong S
Marshall & Gerstein & Borun LLP
LandOfFree
Method of treating latent tuberculosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating latent tuberculosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating latent tuberculosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4069505